Oliver Keown
Oprichter bij Intuitive Ventures/VC/
Profiel
Oliver is managing director and head of Intuitive Ventures.
He joined Intuitive Ventures in 2019 and leads the fund’s investment efforts with a focus on identifying future leaders of minimally invasive care, including early stage startups across digital, medical device, therapeutic and diagnostic domains.
In 2021, Oliver was recognized as a Top 50 Emerging Leader in corporate venture capital and in 2022, selected as #39 on the Global Corporate Venturing Power List of the 100 most influential investors in the industry.
Before coming to Intuitive Ventures, Oliver was a healthcare investor with GE Ventures, driving international startup deal flow and supporting numerous portfolio companies operationally and at the board level.
Prior to that, he advised an array of UK, US and global healthcare innovation projects across technology, government, commercial, and academic fields.
He began his career as a doctor and policy advisor in the UK National Health Service.
He remains dedicated to bringing new technologies, diverse partnerships and investment to address healthcare‘s biggest unmet needs.
He is a widely published author in the fields of healthcare and surgical innovation, and is an advisory board member of the Newsom administration‘s California Initiative to Advance Precision Medicine.
Oliver serves as an investor and Board Observer of Intuitive Ventures portfolio companies, Flywheel.io, Endogenex, SurgeTx, Optellum and KelaHealth.
Oliver holds an MD and BSc in pharmacology from the University of Edinburgh, Scotland.
Actieve functies van Oliver Keown
Bedrijven | Functie | Begin |
---|---|---|
Intuitive Ventures/VC/
Intuitive Ventures/VC/ Investment ManagersFinance Intuitive Ventures/VC/ (Intuitive Ventures) is a venture capital firm founded in 2020 by Oliver Keown. The firm is headquartered in Sunnyvale, California. | Oprichter | 01-01-2019 |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA. | Consultant / Adviseur | 01-01-2019 |
Eerdere bekende functies van Oliver Keown
Bedrijven | Functie | Einde |
---|---|---|
GE Ventures LLC
GE Ventures LLC Investment ManagersFinance GE Ventures LLC (GE Ventures) is a venture capital subsidiary of General Electric Co. founded in 2000 by James Kim. The firm is headquartered in Menlo Park, California. | Private Equity Analist | 31-08-2019 |
Imperial College London | Consultant / Adviseur | 01-09-2016 |
INTUITIVE SURGICAL, INC. | Directeur/Bestuurslid | - |
Opleiding van Oliver Keown
The University of Edinburgh | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INTUITIVE SURGICAL, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
GE Ventures LLC
GE Ventures LLC Investment ManagersFinance GE Ventures LLC (GE Ventures) is a venture capital subsidiary of General Electric Co. founded in 2000 by James Kim. The firm is headquartered in Menlo Park, California. | Finance |
Intuitive Ventures/VC/
Intuitive Ventures/VC/ Investment ManagersFinance Intuitive Ventures/VC/ (Intuitive Ventures) is a venture capital firm founded in 2020 by Oliver Keown. The firm is headquartered in Sunnyvale, California. | Finance |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA. | Health Technology |